Unified Pharmacy + Medical ePA: What DrFirst’s 63% Auto-Fill Rate Means for Clinic Ops

Prior authorization (PA) still sits at the center of prescribing friction for ambulatory clinics and health-system pharmacies. DrFirst’s August 27, 2026 press release reports that its clinical-grade AI fully populates 63% of pharmacy PA question sets with zero clinician edits, with a median open-to-submit time of 49 seconds, and unifies pharmacy plus medical electronic prior authorization (ePA) inside the prescribing workflow. For ops leaders, that is a signal to rethink AI prior authorization pharmacy workflow automation—not as a bolt-on specialty bot, but as build-versus-buy design inside e-prescribing.

AI prior authorization pharmacy workflow automation changes practice when the system pulls chart-backed answers into the PA question set inside the same workflow where the prescription is written—so staff stop re-keying the same diagnosis, try-and-fail, and lab fields across portals. In DrFirst’s reported results, that meant 63% of pharmacy PA question sets fully populated with no clinician edits and a 49-second median from open to submit.

Electronic prior authorization (ePA) is the digital path for submitting PA requests instead of fax and portal hopping. Unifying pharmacy and medical ePA matters because many clinics run two queues, two staff skill sets, and two denial patterns for what is often the same patient visit. When both live in the prescribing workflow, ops can measure one pipeline instead of two shadow systems.

The strategic distinction for leaders: this class of tool sits next to e-prescribing and EHR partners (DrFirst cites reach across 270 EHRs), not as a separate “PA agent” product that only works for one therapy class. Buy decisions should start from workflow ownership, not from demo wow.

Clinics should redesign roles so AI owns first-pass structured completion, clinicians own qualitative chart gaps, and pharmacy or referral staff own queue exceptions and payer follow-up. Keep humans where judgment and documentation nuance live; remove humans from repetitive field mapping they already documented in the chart.

Train to the 63% / 49-second benchmark as a direction of travel, not a guarantee for every payer pack. Your mix of specialty vs primary care, chart completeness, and payer mix will move the numbers. The mid-2026 pilot’s “>90% when one qualitative gap is answered” insight is the coaching cue: make it easy for clinicians to answer that single gap without leaving the e-prescribing surface.

Avoid creating a new shadow spreadsheet for “AI PAs” versus “manual PAs.” One queue, tagged by automation status, keeps audit and staffing honest.

Buy (or expand a platform partner) when your PA pain is high-volume, multi-EHR, and already sitting next to e-prescribing; build custom copilots when you have unique documentation templates, health-system-specific medical PA packets, or orchestration needs the vendor will not roadmap. Most mid-size clinics should not invent a from-scratch PA engine.

Ask vendors to show edit rates, not only “AI assisted” marketing. Zero-edit completion on 63% of pharmacy question sets is a different ops claim than “drafts available.” Ask how medical PA is unified, how overrides are logged, and how denial data returns to the same worklist.

Ops should lock a phased EHR partner rollout, a thin KPI set, and a clinician change plan before Q4 roadmaps freeze—because PA automation fails when it is treated as an IT toggle instead of a queue redesign. Start with high-volume ambulatory clinics that already have cleaner problem lists and med histories.

Use DrFirst’s published 63% zero-edit rate, 49-second median, >2M auto-answered questions across ~150k PAs, and >90% fill rate after one qualitative answer as external reference points—not as contractual promises for your site.

Afaque Designs’ AI Automations work helps health systems and clinics design custom ePA and documentation copilots plus workflow orchestration for pharmacy and medical PA queues—so automation sits where prescribing already happens, with humans reserved for judgment calls.